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OBJECTIVEdTo assess the impact of hyperglycemia in different age-groups of patients with
acute myocardial infarction (AMI).
RESEARCH DESIGN AND METHODSdA total of 2,027 patients with AMI were cat-
egorized into one of ﬁve age-groups:,50 years (n = 301),$50 and,60 (n = 477),$60 and,70
(n = 545),$70 and,80 (n = 495), and$80 years (n = 209). Hyperglycemia was deﬁned as initial
glucose $115 mg/dL.
RESULTSdThe adjusted odds ratios for hyperglycemia predicting hospital mortality in groups
1–5were, respectively, 7.57 (P = 0.004), 3.21 (P = 0.046), 3.50 (P = 0.003), 3.20 (P, 0.001), and
2.16 (P = 0.021). The adjusted P values for correlation between glucose level (as a continuous
variable) and mortality were 0.007, ,0.001, 0.043, ,0.001, and 0.064. The areas under the
ROC curves (AUCs) were 0.785, 0.709, 0.657, 0.648, and 0.613. The AUC in group 1 was
signiﬁcantly higher than those in groups 3–5.
CONCLUSIONSdThe impact of hyperglycemia as a risk factor for hospital mortality in AMI
is more pronounced in younger patients.
Diabetes Care 35:150–152, 2012
E levated glucose level (GL) is an in-dependent risk factor for mortalityin patients with acute myocardial
infarction (AMI) (1–3), in part related to
its adverse effects onmicrocirculation and
left ventricular remodeling (4). Particularly
in older people, hyperglycemia is a com-
mon complication that increases the risk
of death (5). However, less is known about
the impact of hyperglycemia in younger
patients with AMI. Furthermore, the com-
parison of the impact of GL in different age-
groups, particularly in very elderly adults
(.80 years) versus younger adults (,50
years), has not been well studied and is
the primary focus of this study.
RESEARCH DESIGN AND
METHODSdRetrospective analysis of
2,027 patients (median age 64 years, 71.8%
men) with AMI, hospitalized in a single
tertiary center, and included prospectively
in a dedicated databank.
Age-groups
Patients were divided into ﬁve age-
groups:,50 years (group 1, n = 301),$50
and,60 years (group 2, n = 477),$60 and
,70 years (group 3, n = 545),$70 and,80
years (group 4, n = 495), and $80 years
(group 5, n = 209). Hyperglycemia was
deﬁned as ﬁrst glucose measurement
$115 mg/dL (n = 1,025). The time
between symptoms beginning and the
glucose measurement was obtained in
1,752 patients; the median time for the
population was 29 h and similar across
the groups (P value = 0.642). The primary
clinical outcome was in-hospital mor-
tality.
Statistical analyses
Categorical variables are described as
numbers and percentages and continuous
variables as median (25th, 75th percen-
tiles) or mean 6 SD.
For the correlation between hyper-
glycemia and hospital mortality, the x2
test was used, with the Mann-Whitney
U test used for the correlation between
GL (as continuous variable) and mortal-
ity. The mean GL among the groups was
compared with ANOVA. Stepwise logistic
regression method was applied for the
comparison between hyperglycemia as a
categorical variable or GL (continuous
variable) with mortality (dependent vari-
able). Two different models were devel-
oped. The ﬁrst model included age,
hyperglycemia (or GL), sex, ST-elevation
AMI, and a history of angina, dyslipidemia,
relatives with coronary artery disease,
smoking, hypertension, heart failure, dia-
betes, stroke, coronary artery bypass sur-
gery, percutaneous coronary intervention
(PCI), and myocardial infarction. The sec-
ond model included the previous vari-
ables plus primary PCI, nonprimary PCI,
coronary artery bypass surgery, and ﬁbri-
nolytic use during the in-hospital phase.
Because there was no signiﬁcant correla-
tion between LDL or HDL and mortality,
and the P interactions for these variables
and hyperglycemia or GL regarding mor-
tality were nonsigniﬁcant, neither LDL
nor HDL was included in the models.
To analyze the accuracy of GLs in
predicting in-hospital deaths, receiver
operating characteristic (ROC) curves
were constructed for each group and
compared with the DeLong method.
P values ,0.05 were considered signiﬁ-
cant; MedCalc version 11.4.4 statistical
software (MedCalc Software, Mariakerke,
c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c
From the 1Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil; and the
2Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women’s Hospital, Boston,
Massachusetts.
Corresponding author: José Carlos Nicolau, corjnicolau@incor.usp.br.
Received 27 June 2011 and accepted 23 September 2011.
DOI: 10.2337/dc11-1170
© 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and thework is not altered. See http://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
150 DIABETES CARE, VOLUME 35, JANUARY 2012 care.diabetesjournals.org
C a r d i o v a s c u l a r a n d M e t a b o l i c R i s k
B R I E F R E P O R T
Belgium) was used for the ROC curve
comparisons, and SPSS 16.0 (SPSS Inc.,
Chicago, IL)was used for the other analyses.
RESULTSdThe mean GLs (in mg/dL)
for groups 1–5 were, respectively,
125.8 6 62.7, 139.5 6 69.4, 143.9 6
69.6, 143.7 6 69.8, and 136.7 6 72.1.
In comparison with group 1, the P values
for groups 2–5 were, respectively, 0.052,
0.002, 0.003, and 0.398.
GLs were signiﬁcantly higher among
patients who died in hospital compared
with survivors in all age-groups. More-
over, the mean difference in GL between
deceased and survivors was larger in the
youngest population when compared
with the eldest population (65.6 6 16.2
vs. 22.9 6 11.1 mg/dL, P , 0.001). The
adjusted t ratios (P values) for groups 1–5
in the ﬁrst model (only baseline variables)
were, respectively, 2.96 (P = 0.003), 4.47
(P , 0.001), 2.04 (P = 0.042), 3.48 (P ,
0.001), and 1.85 (P = 0.064); for the
second model (baseline variables + in-
hospital interventions), the respective
ﬁgures were 2.71 (P = 0.007), 4.47
(P = 0.007), 2.04 (P = 0.042), 3.48
(P , 0.001), and 1.85 (P = 0.064).
By univariate analyses, the odds ratios
(P values) for in-hospital mortality in pa-
tients with hyperglycemia were the fol-
lowing for groups 1–5: 7.22 (P = 0.001),
3.17 (P = 0.038), 3.15 (P = 0.003), 3.31
(P, 0.001), and 2.07 (P = 0.021), respec-
tively. In the ﬁrst adjusted model (base-
line variables), the respective group
ﬁgures were 6.93 (P = 0.004), 3.21 (P =
0.046), 3.42 (P = 0.004), 3.20 (P, 0.001),
and 2.25 (P = 0.013). In the second ad-
justed model (baseline + in-hospital vari-
ables), theﬁgureswere 7.57 (P=0.004), 3.21
(P = 0.046), 3.50 (P = 0.003), 3.20 (P ,
0.001), and 2.16 (P = 0.021), respectively.
The results of the area under the ROC
curves (AUCs) are depicted in Table 1,
with best results obtained for the youn-
gest population (AUC = 0.785) and the
lowest AUC in the eldest population
(AUC = 0.613).
DISCUSSIONdThe main ﬁnding of
our study is the observation that hyper-
glycemia in patients with AMI is a better
predictor for mortality in younger pa-
tients than in the elderly population. The
increased mortality related to hypergly-
cemia in AMI patients has been linked to
different pathophysiologic mechanisms
(6–8), such as increased oxidative stress,
inﬂammation, and activation of stress-
responsive kinases. Moreover, hyperglyce-
mia is strongly correlated with impaired
coronary ﬂow before reperfusion and has
been associated with enhanced thrombin
formation, platelet activation, and ﬁbrin
clot resistance to lysis. In addition, hyper-
glycemia has been linked to increased sen-
sitivity to ischemia-reperfusion injury
(9,10). Since the individual response to
these processes (among others) varies
with age, this could explain, at least in
part, our results.
Another explanation for our ﬁndings
(not exclusive of the previous) relates
to the importance of age itself as a risk
factor for mortality. Since advanced age
is a strong independent risk factor for
mortality in patients with AMI, hypergly-
cemia may have a relatively greater im-
portance in younger populations and a
weaker impact in the elderly population.
Clinical implications
There have been conﬂicting results re-
garding the clinical beneﬁt of intensive
glucose control in AMI patients (11–13).
Several possible explanations for the lack
of consistent beneﬁt with intensive glu-
cose management have been proposed,
but the leading hypothesis is that it leads
to a higher incidence of hypoglycemia,
which is quite deleterious in AMI patients
(14). Our results add another nuance to
this debate: intensive glucose control may
have different effects depending on the
age of the patient.
CONCLUSIONSdThe value of hyper-
glycemia as a risk factor for in-hospital
mortality in patients with AMI is not
homogeneous, with a greater relative im-
pact on mortality in the younger popu-
lation. This ﬁnding may have clinical
implications regarding the therapeutic
approach to hyperglycemia in patients
with AMI (15).
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